Ad-hoc-Releases
-
There are no current ad hoc releases available.
-
2021‑05‑06 | DGAP-Ad-hoc
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share 06-May-2021 / 20:07 CET/CEST Disclosure of a...
Read more...
Corporate News
-
2022‑08‑11 | DGAP-News
APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed
DGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Report/Half Year Results APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed Read more...
2022‑07‑19 | DGAP-NewsAPONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a ...
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance/Market launch APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan-European i...
Read more...2022‑07‑06 | DGAP-NewsAPONTIS PHARMA rolls out new Single Pill for secondary prophylaxis
DGAP-News: APONTIS PHARMA AG / Key word(s): Market launch APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis 06.07.2022 / 07:30 ...
Read more...2022‑06‑23 | DGAP-NewsAPONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG / Key word(s): Share Buyback APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 2...
Read more...2022‑05‑25 | DGAP-NewsAPONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million 25.0...
Read more...2022‑05‑12 | DGAP-NewsAPONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large ...
DGAP-News: APONTIS PHARMA AG / Key word(s): AGM/EGM APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large majorities Read more...
2022‑05‑10 | DGAP-NewsAPONTIS PHARMA continues strong profitable growth in Q1 2022
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement APONTIS PHARMA continues strong profitable growth in Q1 2022 10.05.2022 / 07:30 Read more...
2022‑05‑05 | DGAP-NewsAPONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with ...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights...
Read more...2022‑04‑20 | DGAP-NewsAPONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of car...
DGAP-News: APONTIS PHARMA AG / Key word(s): Scientific publication APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pi...
Read more...2022‑03‑16 | DGAP-NewsAPONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular even...
DGAP-News: APONTIS PHARMA AG / Key word(s): Scientific publication 16.03.2022 / 07:30 The issuer is solely responsible for the content of this announc...
Read more...2022‑03‑15 | DGAP-NewsAPONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG / Key word(s): Share Buyback 15.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement.
2022‑03‑08 | DGAP-NewsAPONTIS PHARMA and AstraZeneca extend strategic sales cooperation
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 08.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement. ...
Read more...2022‑03‑03 | DGAP-NewsAPONTIS PHARMA reports successful financial year 2021 - Single Pills as growth driver
DGAP-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Annual Results 03.03.2022 / 07:30 The issuer is solely responsible for the content of ...
Read more... -
2021‑12‑16 | DGAP-News
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA AG / Key word(s): Personnel 16.12.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...
Read more...2021‑12‑14 | DGAP-NewsAPONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-Euro...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch/Alliance 14.12.2021 / 07:30 The issuer is solely responsible for the content of this announ...
Read more...2021‑11‑18 | DGAP-NewsAPONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Re...
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/9 Month figures 18.11.2021 / 07:30 The issuer is solely responsible for the ...
Read more...2021‑10‑26 | DGAP-NewsAPONTIS PHARMA announces market launch of new Single Pill
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 26.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement.
2021‑09‑14 | DGAP-NewsAPONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and ...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 14.09.2021 / 07:30 The issuer is solely responsible for the content of this announcement.
2021‑08‑11 | DGAP-NewsAPONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figur...
DGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report 11.08.2021 / 07:30 The issuer is solely responsible for the content of ...
Read more...2021‑07‑28 | DGAP-NewsAPONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 1...
DGAP-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Half Year Results 28.07.2021 / 07:30 The issuer is solely responsible for the content ...
Read more...2021‑07‑12 | DGAP-NewsAPONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...
Read more...2021‑06‑18 | DGAP-NewsAPONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 1...
DGAP-News: APONTIS PHARMA AG / Key word(s): Research Update 18.06.2021 / 07:30 The issuer is solely responsible for the content of this announcement.<...
Read more...2021‑06‑10 | DGAP-NewsAPONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:23 The issuer is solely responsible for the content of this announcement.
2021‑06‑10 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:20 The issuer is solely responsible for the content of this announcement.
2021‑05‑28 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 28.05.2021 / 20:05 The issuer is solely responsible for the content of this announcement.
2021‑05‑20 | DGAP-NewsAPONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues i...
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement 20.05.2021 / 07:30 The issuer is solely responsible for the content of this ...
Read more...2021‑05‑19 | DGAP-NewsAPONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 19.05.2021 / 20:23 The issuer is solely responsible for the content of this announcement.
2021‑05‑14 | EQS-NewsApontis Pharma (APPH): Initiation - A phoenix rises
Edison Investment Research Limited 14-May-2021 / 07:00 GMT/BST
Financial Reports
Financial Calendar
-
Mar 03, 2022
Preliminary (unaudited) annual figures 2021 / Earnings Call
Mar 30, 2022Annual Report 2021
May, 2022MKK – Münchner Kapitalmarkt Konferenz (May 3 - 4, 2022)
MunichMay 10, 2022Interim Statement 3M/Q1 2022 / Earnings Call
May 12, 2022Annual General Meeting
DusseldorfMay 18, 2022PLATOW Euro Finance Small Cap Conference
Frankfurt (Main)Jun 24, 2022Warburg Highlights Conference
HamburgJun 29, 202234. Prior Kapitalmarktkonferenz
Frankfurt (Main)Aug 11, 2022Half-year Report 2022 / Earnings Call
Aug 25, 2022Hamburger Investorentag (HIT)
HamburgSep 05, 2022German Fall Conference
Frankfurt (Main)October, 2022CF&B European MidCap Event
ParisNov 10, 2022Interim Statement 9M/Q3 2022 / Earnings Call
Nov 28, 2022EKF Deutsches Eigenkapitalforum
Frankfurt (Main) -
February, 2021
2020 Annual Report
April, 2021Annual General Meeting 2021
Jul 28, 2021Preliminary half-year figures
Aug 11, 2021Publication of half-year financial statements / Conference call 14.00 CST
Aug 26, 2021Hamburger Investorentag (HIT)
HamburgSeptember, 2021Roadshow
Sep 06, 2021Equity Forum German Fall Conference
Frankfurt/MainNov 18, 2021Quarterly Statement 9M 2021
Nov 22, 2021German Equity Forum
Frankfurt/Main
Managers' Transactions
-
There are no current managers’ transactions available.
-
There are no current managers’ transactions available.
Other mandatory notifications
There are no other mandatory notifications available.
